Rounds focused on critically ill pediatric patients at the greatest risk for developing health care–associated conditions (HACs) reduced the rate of specific HACs by nearly 50% at a Colorado hospital, according to a study published in Critical Care Nurse. After implementing a high-risk rounding process, Children’s Hospital Colorado, Aurora, was able to decrease the mean rate of project-specific HACs in its pediatric intensive care unit (PICU) from 5.41 to 2.89 events per 1,000 patient days. The 48-bed PICU averages 3,500 admissions annually from across the seven states served by the hospital.

Panic disorder (PD) is a mental health disorder characterized by recurring panic attacks, episodes of intense fear and anxiety accompanied by physical sensations and physiological responses such as a racing heart, shortness of breath, dizziness, blurred vision and other symptoms. Estimates suggest that approximately 2–3% of people worldwide experience PD at some point during their lives.

“House burping” is the latest thing cluttering people’s feeds: short clips of people flinging open every window and door, announcing they’re “burping” their home to get rid of stale, germ-filled air. Behind the playful name is a serious question: does this actually make a home healthier, or are people just swapping indoor germs for outdoor pollution?

There is no known cure for Huntington’s disease. A genetic mutation creates harmful proteins that accumulate and cause the disease’s typical symptoms. A team from the Department of Human Genetics at Ruhr University Bochum, Germany, has now shown how targeted ubiquitin tagging at two positions in the mutated huntingtin protein affects its breakdown and distribution within the cell. This insight could provide a starting point for future therapies. The team in Bochum, led by Professor Hoa Huu Phuc Nguyen, worked closely with Israeli researcher Professor Aaron Ciechanover, who was awarded the Nobel Prize in Chemistry in 2004 for his work on the protein degradation system.

Selecting the healthiest embryo is one of the most important steps in in‑vitro fertilization (IVF), yet it remains one of the most uncertain. Roughly 15% of couples worldwide experience infertility, and IVF success rates often remain below 33%. A major challenge is that embryologists must choose a single embryo to implant, relying on what they can see under a microscope.